Commentary: something new to consider in the treatment of Helicobacter pylori infection? Authors' reply.
Internal Medicine Department, Holy Family Hospital, Faculty of Medicine in the Galilee, Bar-Ilan University, Nazareth, Israel. w.nseir@yahoo.com
W
W
Nseir
J
J
Mograbi
O
O
Abu-Elheja
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D008297:Male; D054328:Proton Pump Inhibitors / Q000008:administration & dosage*; D019821:Simvastatin / Q000008:administration & dosage*
D000900:Anti-Bacterial Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D054328:Proton Pump Inhibitors; D019821:Simvastatin